Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On December 4, 2012, Dex One Corporation (the "Company") was notified by the New York Stock Exchange (the "NYSE") that the Company had fallen below one of the NYSE's continued listing standards. Rule 802.01C of the NYSE Listed Company Manual requires that the average closing price of the Company's common stock over a consecutive 30 trading-day period equal or exceed $1.00 per share.

Under applicable NYSE rules, the Company has 10 business days from receipt of the notice to inform the NYSE that it intends to cure the deficiency and until its next annual meeting of stockholders to bring its share price and average share price back above $1.00. The Company notified the NYSE that it intends to cure the deficiency within the prescribed timeframe.

As required under NYSE rules, the Company issued a Press Release on December 10, 2012, announcing that it had received the notice of non-compliance and that the Company intends to cure the deficiency within the prescribed timeframe. A copy of this press release is attached hereto as Exhibit 99.1 to this Form 8-K.

Item 9.01 Financial Statements and Exhibits.

Exhibit Number Description 99.1 Press Release, issued December 10, 2012.

---